Special Issue "Epidemiology and Control of Malaria"
A special issue of Diseases (ISSN 2079-9721).
Deadline for manuscript submissions: closed (15 December 2013)
Dr. Xiaohua Jiang (Website)
Pharmacenter, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
Phone: +41 61 267 15 58
Interests: urine tract infection (UTI); synthesis of glycomimetics as potential Selectin antagonists; carbohydrate research
Malaria is an infectious disease caused by protozoan parasites from the Plasmodium family that can be transmitted by the sting of the Anopheles mosquito or by a contaminated needle or transfusion. Although mainly four species of the genus cause malaria, Plasmodium falciparum is responsible for the most severe and deadly form of the disease. WHO estimates that 219 million cases of malaria occurred worldwide in 2010 (uncertainty range: 154 million to 289 million) and about 660,000 people died from the disease (uncertainty range: 490,000 to 836,000), mostly children under five years of age in sub-Saharan Africa.
Malaria is strongly associated with poverty. During the last decade, malaria-endemic countries have witnessed a historic increase in the amount of resources dedicated to fight the disease through the support of the Roll Back Malaria Partnership, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and The President’s Malaria Initiative. Malaria researchers and policy makers have taken advantage of heightened global malaria awareness to shift their focus to a rapid expansion of effective malaria control programs while downplaying issues related to sustainability of these programs. Defeating malaria will require a high level of political commitment, strengthened regional cooperation, and the engagement of a number of sectors outside of health, including finance, education, defense, environment, mining, industry and tourism. Despite continuous efforts to control malaria, it remains a major health problem in the tropical world. Malaria-endemic areas are more connected to the rest of the world than at any time in history, with the disease able to travel at speeds of 600 miles per hour within infected passengers.
The aim with this Special Issue of Disease is to offer an Open Access collection of papers related to Epidemiology and control of Malaria around the world, to awake more awareness about the importance of fighting against this disease in all endemic countries and non-endemic countries.
Dr. Xiaohua Jiang
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- Anopheles mosquito
- Plasmodium falciparum
- Plasmodium vivax
- Plasmodium ovale
- indoor residual spraying (IRS)
- insecticide-treated net (ITN)
- insecticide resistance
- intermittent preventive treatment (IPT)
- seasonal malaria chemoprevention (SMC)
- millennium development goal (MDG)